Trials / Terminated
TerminatedNCT02266121
Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis
Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis / Améliorer Les capacités Cognitives Par tDCS Chez Les Patients Souffrants de sclérose en Plaques
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- University Hospital of Mont-Godinne · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Noninvasive brain stimulations (NIBS) will be used in MS patients with cognitive impairments to enhance their cognitive aptitudes.
Detailed description
tDCS will be used in a sham-controlled, double-blind, randomized, cross-over control trial in MS patients suffering from cognitive impairments and/or motor deficits. After informed consent and recruitment, patients will be randomly (computer method) allocated to real or sham tDCS, that will be applied during working memory and attentional tasks. A few days/weeks after completing one arm, the patients will enter the other arm (double-blind cross-over design). Baseline and follow-up outcomes about cognitive aptitudes, motor tasks and fatigue will be collected.
Conditions
- Relapsing Remitting Multiple Sclerosis
- Secondary-progressive Multiple Sclerosis
- Cognitive Deficits
- Motor Deficits
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | tDCS | Device: transcranial direct current stimulation tDCS tdcs (ELDITH, Neuroconn, Ilmenau, Germany) |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2023-05-08
- Completion
- 2023-05-08
- First posted
- 2014-10-16
- Last updated
- 2023-05-09
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02266121. Inclusion in this directory is not an endorsement.